Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment

INTRODUCTION: There is a need to identify effective, safe treatments for COVID-19 (coronavirus disease) rapidly, given the current, ongoing pandemic. A systematic benefit–risk assessment was designed and conducted to examine the benefit–risk profile of remdesivir in COVID-19 patients compared with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Miranda, Osborne, Vicki, Lane, Samantha, Roy, Debabrata, Dhanda, Sandeep, Evans, Alison, Shakir, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255634/
https://www.ncbi.nlm.nih.gov/pubmed/32468196
http://dx.doi.org/10.1007/s40264-020-00952-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255634/
https://www.ncbi.nlm.nih.gov/pubmed/32468196
http://dx.doi.org/10.1007/s40264-020-00952-1

Ejemplares similares